Today, the UB and the biomedical company Atrys Health, specialized in precision medicine, have signed a collaboration agreement to create the Personalized Radiotherapy Chair, which will be led by Ferran Guedea, head of the IDIBELL Radiobiology and Cancer Group.
IDIBELL will receive almost 630,000 euros from La Marató de TV3 and Catalunya Radio to carry out five projects. The funded studies will focus on the research of factors to predict COVID-19 complications and testing vaccines in vulnerable patients.
Identification of the miR-518d-5p molecule in blood is associated with increased resistance to sorafenib treatment and reduced overall survival in patients with hepatocellular carcinoma
A study by IDIBELL and UB shows that participation in a workshop combining scientific training and theatre performance reduces implicit biases against physical illnesses
A study of IDIBELL, ICO, and Bellvitge University Hospital shows that exercise not only prevents the loss of neuronal tissue caused by chemotherapy and radiotherapy. Also, patients who follow sports guidelines increase the volume of gray matter in the brain regions involved in memory and learning functions, such as the hippocampus.
An international study, with the participation of IDIBELL and ICO, determines that the metabolism of breast tumor cells is defined by their origin.
